Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
Authors:
Open Access
- 12 December 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 510
Abstract
Background: Infants born extremely preterm are at high risk of developing bronchopulmonary dysplasia (BPD). This study aimed to assess the incremental health care burden of BPD and associated comorbidities among extremely preterm infants in the United States. Methods: Health service claims in the Premier Perspective database were retrospectively analyzed for infants born at ≤28 weeks gestation who were admitted to neonatal intensive care during birth hospitalization and survived to a postmenstrual age of ≥36 weeks. Gestational age (GA) at birth and BPD status of infants was determined based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes recorded in the database. Results: Of the 12,017 infants included, 4,904 (40.8%) had BPD. BPD increased with decreasing GA: 67.4% of infants born at P < 0.001), and incurred higher total charges (mean [SD] $799,499 [$535,528] vs. $588,949 [$377,137], respectively, P < 0.001). Mean total charges incurred during index hospitalization decreased as GA at birth increased, with GA having a bigger effect than presence or absence of BPD. During their first year, infants with BPD had a higher in-hospital late mortality rate than those without (1.9 vs. 0.6%), and were more likely to have two or more hospital encounters following birth hospitalization (58.0 vs. 48.2%). Among infants who had two or more encounters after discharge, those with BPD experienced a higher percentage of pulmonary symptoms than those without (46.3 vs. 38.9%). Comparison with infants who did not have BPD, retinopathy of prematurity, or intraventricular hemorrhage showed that BPD is the main complication contributing to increased length of stay, costs, in-hospital mortality, and additional health care encounters. Conclusion: BPD is a key contributor to the large health care burden associated with extremely preterm birth. However, GA at birth has a bigger effect on health care costs for extremely preterm infants than the presence of BPD.Keywords
Funding Information
- Takeda Pharmaceutical Company
This publication has 17 references indexed in Scilit:
- Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012JAMA, 2015
- Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary DysplasiaAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Outcomes for Extremely Premature InfantsAnesthesia & Analgesia, 2015
- Births: final data for 2013.2015
- Disrupted lung development and bronchopulmonary dysplasiaCurrent Opinion in Pediatrics, 2014
- Epidemiology of bronchopulmonary dysplasiaBirth Defects Research Part A: Clinical and Molecular Teratology, 2014
- Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010Pediatric Research, 2013
- Cost of Morbidities in Very Low Birth Weight InfantsThe Journal of Pediatrics, 2013
- Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stayJournal of Perinatology, 2006
- Rehospitalization in the first year of life among infants with bronchopulmonary dysplasiaThe Journal of Pediatrics, 2004